Gain Therapeutics, Inc. announced the appointment of Gene Mack, MBA as its chief financial officer, effective as of April 8, 2024. Gene has over 25 years of experience in the life sciences sector spanning clinical research, financing and capital markets, investing, corporate strategy and business development. Prior to joining Gain, Gene was CFO at privately held Imcyse SA between 2021 and 2023.

Prior to Imcyse, Gene was CFO at OncoC4. Before that, he has held the CFO role for several development- and commercial-stage biopharmaceutical companies, raising over $350 million in IPO and other equity transactions. Prior to his operational experience, Gene covered the biotechnology and life sciences sector as a senior publishing analyst at various investment banks, including Gruntal & Co, Lazard, Mizuho, and HSBC.

Gene received his BS in Biochemistry and MBA in Finance from Fordham University.